Skip to main content
. Author manuscript; available in PMC: 2018 Oct 13.
Published in final edited form as: Vaccine. 2017 Sep 12;35(43):5819–5827. doi: 10.1016/j.vaccine.2017.09.025

Table 1.

Clinical presentation and treatment of cholera and non-cholera diarrhea cases

Cholera
diarrhea cases
N=181a
Non-cholera
diarrhea cases
N=157a

Variable n (%) n (%)
Time from symptom onset to admission (days)b,c 0 [0 – 1] 0 [0 – 1]
Serotype
  Ogawa 148 (82) Not applicable
  Inaba 33 (18) Not applicable
Cholera treatment center
  A 63 (35) 43 (28)
  B 40 (22) 36 (23)
  C 28 (15) 45 (29)
  D 49 (27) 32 (21)
Dehydration stage at presentation
  A (Mild) 19 (11) 48 (31)
  B (Moderate) 64 (36) 74 (47)
  C (Severe) 97 (54) 34 (22)
Treatment received at clinic
  Oral rehydration solution 174 (97) 153 (98)
  Intravenous fluids 158 (88) 85 (54)
  Antibiotics 93 (52) 50 (32)
Amount of oral rehydration solution given in clinic (liters)b,d 8 [4 – 12] 4 [2 – 6]
Amount of intravenous fluids fluid given in clinic (liters)b,e 7 [3 – 15] 2 [1 – 5]
Admitted overnight to the cholera treatment unit 175 (97) 125 (80)
Duration of stay at cholera treatment unit (days)b,f 3 [2 – 5] 1 [1 – 2]
Outcome
  Discharged 166 (92) 144 (92)
  Transferred 2 (1) 6 (4)
  Died 7 (4) 1 (1)
  Left against medical advice 5 (3) 5 (3)
a

With the exception of cholera serotype (N=181), clinical data was not obtained for one cholera diarrhea case and one non-cholera diarrhea case, thus effective samples sizes are 180 and 156, respectively, for all other variables, unless otherwise noted.

b

Median [interquartile range]

c

Data available for 178 cholera diarrhea cases

d

Among those given oral rehydration solution. Data available for 167 cholera diarrhea cases, 150 non-cholera diarrhea cases

e

Among those given intravenous fluids. Data available for 158 cholera diarrhea cases, 85 non-cholera diarrhea cases.

f

Among those admitted overnight. Data available for 175 cholera diarrhea cases, 125 non-cholera diarrhea cases